SSKN
STRATA Skin Sciences, Inc.
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Last price
0.00
▲ 0.00 (100.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
—
Prev close
0.00
Day high
0.13
Day low
0.12
Volume
4.88K
Market cap
$1.18K
P/E (TTM)
—
52W range
0.00 – 3.86
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
587.29K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Nov 18, 25 | RUBINSTEIN SAMUEL Director |
BUY | 5.00K | $7.03K | Direct |
| Nov 17, 25 | RUBINSTEIN SAMUEL Director |
SELL | 14.09K | $18.80K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
RUBINSTEIN SAMUEL |
Director | 8.77K | Purchase |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
-75.00%
-78.7%
3M
-99.93%
-103.0%
6M
-99.95%
-111.0%
YTD
-99.99%
-112.3%
1Y
-99.99%
-120.0%
3Y
-99.98%
-174.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.18K
Enterprise value$8.36M
Revenue (TTM)$30.70M
Gross profit$17.88M
EBITDA$-1.71M
Net income$-6.26M
EPS (TTM)$-2.70
Free cash flow$-1.33M
Total cash$7.91M
Total debt$16.27M
Book value / share$0.49
Shares outstanding5.89M
Float4.20M
Short % of float8.13%
Dividend yield—
Beta (5Y)0.03
Short interest
Shares short
358.99K
Prior 294.15K
Change vs prior
+22.0%
Shorts adding
% of float
8.13%
Normal
% of shares out
6.10%
Against total outstanding
Days to cover
5.3
Crowded exit
Float
4.20M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.00
PEG ratio0.03
Price / sales—
Price / book0.00
EV / revenue0.27
EV / EBITDA-4.88
Gross margin58.25%
Operating margin0.40%
Profit margin-20.40%
Return on equity-158.91%
Return on assets-11.14%
Debt / equity559.42
Current ratio0.58
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $30.70M | $33.56M | $33.36M | $36.16M | — | -8.5% |
| Operating revenue | $30.70M | $33.56M | $33.36M | $36.16M | — | -8.5% |
| Cost of revenue | $12.81M | $14.34M | $14.90M | $14.39M | — | -10.6% |
| Gross profit | $17.88M | $19.22M | $18.46M | $21.77M | — | -7.0% |
| Research & development | $421.00K | $883.00K | $1.32M | $1.03M | — | -52.3% |
| Selling, general & admin | $23.30M | $23.33M | $23.46M | $25.39M | — | -0.1% |
| Total operating expense | $23.72M | $24.21M | $24.78M | $26.42M | — | -2.0% |
| Operating income | -$5.83M | -$4.99M | -$6.32M | -$4.65M | — | -17.0% |
| Net interest income | -$1.55M | -$1.86M | -$1.41M | -$837.00K | — | +16.9% |
| Pre-tax income | -$6.25M | -$10.26M | -$10.92M | -$5.49M | — | +39.1% |
| Tax provision | $12.00K | -$170.00K | -$92.00K | $63.00K | — | +107.1% |
| Net income | -$6.26M | -$10.09M | -$10.83M | -$5.55M | — | +37.9% |
| Net income to common | -$6.26M | -$10.09M | -$10.83M | -$5.55M | — | +37.9% |
| Basic EPS | — | -2.65 | -3.10 | -1.60 | -0.80 | — |
| Diluted EPS | — | -2.65 | -3.10 | -1.60 | -0.80 | — |
| EBIT | -$4.29M | -$8.15M | -$9.28M | -$4.56M | — | +47.4% |
| EBITDA | $177.00K | -$2.84M | -$3.38M | $1.13M | — | +106.2% |
| Basic shares | — | 3.81M | 3.49M | 3.47M | 3.41M | — |
| Diluted shares | — | 3.81M | 3.49M | 3.47M | 3.41M | — |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.91M | $7.26M | $6.78M | $5.43M | — | +9.0% |
| Cash & short-term investments | $7.91M | $7.26M | $6.78M | $5.43M | — | +9.0% |
| Accounts receivable | $4.12M | $5.25M | $4.44M | $4.47M | — | -21.5% |
| Inventory | $2.81M | $2.25M | $2.67M | $3.10M | — | +25.3% |
| Total current assets | $15.60M | $16.59M | $15.54M | $15.05M | — | -6.0% |
| Property, plant & equipment | $9.88M | $11.32M | $12.40M | $10.93M | — | -12.7% |
| Goodwill & intangibles | $4.81M | $6.78M | $13.84M | $26.20M | — | -29.1% |
| Total assets | $30.52M | $34.93M | $42.02M | $52.27M | — | -12.6% |
| Total current liabilities | $26.74M | $13.40M | $12.17M | $13.43M | — | +99.6% |
| Current debt | $15.35M | — | — | — | — | — |
| Long-term debt | — | $15.19M | $15.04M | $7.48M | $7.32M | — |
| Total debt | $16.27M | $16.44M | $15.63M | $8.44M | — | -1.0% |
| Total liabilities | $27.61M | $29.96M | $29.33M | $30.44M | — | -7.8% |
| Retained earnings | -$254.41M | -$248.14M | -$238.06M | -$227.23M | — | -2.5% |
| Shareholder equity | $2.91M | $4.97M | $12.69M | $21.83M | — | -41.5% |
| Working capital | -$11.14M | $3.20M | $3.37M | $1.63M | — | -448.3% |
| Net tangible assets | -$1.90M | -$1.80M | -$1.15M | -$4.37M | — | -5.2% |
| Shares issued | 5.89M | 4.17M | 3.51M | 3.47M | — | +41.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$6.26M | -$10.09M | -$10.83M | -$5.55M | +37.9% |
| Depreciation & amortisation | $4.47M | $5.31M | $5.90M | $5.69M | -15.8% |
| Stock-based compensation | $643.00K | $427.00K | $1.30M | $1.47M | +50.6% |
| Change in working capital | — | $281.00K | — | -$2.88M | — |
| Operating cash flow | -$2.79M | $188.00K | -$519.00K | -$924.00K | -1,586.2% |
| Capital expenditure | -$1.47M | -$1.64M | -$5.02M | -$3.74M | +10.3% |
| Investing cash flow | -$1.47M | -$1.64M | -$5.02M | -$4.37M | +10.3% |
| Financing cash flow | $3.58M | $1.93M | $6.86M | -$500.00K | +85.9% |
| Free cash flow | -$4.26M | -$1.45M | -$5.54M | -$4.66M | -194.3% |
| End cash position | $7.91M | $8.60M | $8.12M | $6.79M | -7.9% |
| Line item | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $9.29M | $6.93M | $7.66M | $6.81M | $9.58M | +34.1% |
| Operating revenue | $9.29M | $6.93M | $7.66M | $6.81M | $9.58M | +34.1% |
| Cost of revenue | $3.68M | $2.75M | $3.36M | $3.17M | $3.82M | +34.0% |
| Gross profit | $5.61M | $4.18M | $4.31M | $3.65M | $5.76M | +34.2% |
| Research & development | $67.00K | $172.00K | $86.00K | $96.00K | $200.00K | -61.0% |
| Selling, general & admin | $5.51M | $5.87M | $6.44M | $5.57M | $5.92M | -6.1% |
| Total operating expense | $6.26M | $5.36M | $6.53M | $5.66M | $6.12M | +16.9% |
| Operating income | -$647.00K | -$1.17M | -$2.22M | -$2.02M | -$366.00K | +44.8% |
| Net interest income | -$418.00K | -$449.00K | -$265.00K | -$417.00K | -$440.00K | +6.9% |
| Pre-tax income | $70.00K | -$1.62M | -$2.49M | -$2.43M | -$4.67M | +104.3% |
| Net income | $58.00K | -$1.62M | -$2.49M | -$2.43M | -$4.50M | +103.6% |
| Net income to common | $58.00K | -$1.62M | -$2.49M | -$2.43M | -$4.50M | +103.6% |
| Basic EPS | — | -0.36 | -0.60 | -0.58 | — | — |
| Diluted EPS | — | -0.36 | -0.60 | -0.58 | — | — |
| EBIT | $554.00K | -$1.12M | -$2.00M | -$1.95M | -$4.15M | +149.3% |
| EBITDA | $1.46M | -$173.00K | -$693.00K | -$641.00K | -$2.84M | +943.9% |
| Basic shares | — | 4.48M | 4.17M | 4.17M | — | — |
| Diluted shares | — | 4.48M | 4.17M | 4.17M | — | — |
| Line item | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.91M | $7.08M | $5.97M | $6.51M | $7.26M | +11.8% |
| Cash & short-term investments | $7.91M | $7.08M | $5.97M | $6.51M | $7.26M | +11.8% |
| Accounts receivable | $4.12M | $3.50M | $4.02M | $5.01M | $5.25M | +17.6% |
| Inventory | $2.81M | $3.06M | $3.24M | $2.66M | $2.25M | -8.0% |
| Total current assets | $15.60M | $14.27M | $13.77M | $15.88M | $16.59M | +9.3% |
| Property, plant & equipment | $9.88M | $10.56M | $9.70M | $10.64M | $11.32M | -6.4% |
| Goodwill & intangibles | $4.81M | $5.65M | $7.02M | $7.51M | $6.78M | -15.0% |
| Total assets | $30.52M | $30.72M | $30.72M | $34.26M | $34.93M | -0.6% |
| Total current liabilities | $26.74M | $15.03M | $14.00M | $15.14M | $13.40M | +77.9% |
| Current debt | $15.35M | $1.88M | — | — | — | +718.6% |
| Long-term debt | — | $13.44M | $15.27M | $15.23M | $15.19M | — |
| Total debt | $16.27M | $16.31M | $16.35M | $16.40M | $16.44M | -0.3% |
| Total liabilities | $27.61M | $29.40M | $30.41M | $31.59M | $29.96M | -6.1% |
| Retained earnings | -$254.41M | -$254.46M | -$253.06M | -$250.58M | -$248.14M | +0.0% |
| Shareholder equity | $2.91M | $1.31M | $308.00K | $2.67M | $4.97M | +121.3% |
| Working capital | -$11.14M | -$761.00K | -$230.00K | $737.00K | $3.20M | -1,364.0% |
| Net tangible assets | -$1.90M | -$4.34M | -$6.71M | -$4.84M | -$1.80M | +56.2% |
| Shares issued | 5.89M | 5.27M | 4.17M | 4.17M | 4.17M | +11.8% |
| Line item | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $58.00K | -$1.40M | -$2.49M | -$2.43M | -$4.50M | +104.1% |
| Depreciation & amortisation | $906.00K | $951.00K | $1.30M | $1.30M | $1.31M | -4.7% |
| Stock-based compensation | $174.00K | $212.00K | $128.00K | $129.00K | $126.00K | -17.9% |
| Change in working capital | -$987.00K | $845.00K | -$1.01M | $265.00K | $156.00K | -216.8% |
| Operating cash flow | -$239.00K | -$64.00K | -$1.94M | -$550.00K | $703.00K | -273.4% |
| Capital expenditure | -$312.00K | -$1.02M | — | -$199.00K | -$504.00K | +69.4% |
| Investing cash flow | -$312.00K | -$1.02M | $61.00K | -$199.00K | -$504.00K | +69.4% |
| Financing cash flow | $1.39M | $2.19M | $0 | $0 | $0 | -36.7% |
| Free cash flow | -$551.00K | -$1.08M | -$1.88M | -$749.00K | $199.00K | +49.1% |
| End cash position | $7.91M | $7.08M | $5.97M | $7.85M | $8.60M | +11.8% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Sep 2025 | -0.24 | -0.36 | -49.0% |
| Jun 2025 | -0.27 | -0.60 | -122.2% |
| Mar 2025 | -0.56 | -0.58 | -3.6% |
| Dec 2024 | -0.40 | 0.29 | +171.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders9.97%
Held by institutions25.38%
Institutions holding2
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 27, 25 | Maxim Group | INITIATED | — | Buy |
| May 16, 23 | CG Capital | MAINTAINED | — | Outperform |
| Nov 3, 20 | HC Wainwright & Co. | UPGRADE | Neutral | Buy |
| Mar 17, 20 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Dec 9, 19 | Ladenburg Thalmann | INITIATED | — | Buy |
| Nov 21, 19 | Oppenheimer | INITIATED | — | Outperform |
| Dec 10, 18 | Northland Capital Markets | INITIATED | — | Outperform |
Moving averages & technicals
SMA 10
0.00
+81.82% from price
SMA 20
0.00
-96.40% from price
SMA 50
0.05
-99.79% from price
SMA 100
0.10
-99.80% from price
SMA 200
0.55
-99.98% from price
EMA 12
0.00
-87.54% from price
EMA 26
0.01
-98.45% from price
EMA 50
0.05
-99.57% from price
RSI (14)
26.0
Oversold
MACD (12,26,9)
-0.01
Hist 0.00
ATR (14)
0.00
400.00% of price
Realised vol 30D
1429.4%
Annualised
Bollinger upper
0.01
20, 2σ
Bollinger lower
-0.00
20, 2σ
50 / 200 cross
Death
0.05 vs 0.55
Trend bias
Below 200
-99.98%
Risk profile
Beta vs SPY
-2.24
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
1429.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-100.0%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
400.00% of price
Beta (reported)
0.03
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateApr 7, 2017
Last split1:10
Split dateJun 7, 2024
SEC filings
Periodic Financial Reports
10-K · 2026-03-26
Notice of termination of registration of a class of securities under Section 12(g)
15-12G · 2026-03-02
Offering Registrations
S-8 POS · 2026-02-27
Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
25 · 2026-02-19
Corporate Changes & Voting Matters
8-K · 2026-02-11
Corporate Changes & Voting Matters
8-K · 2025-12-17
Corporate Changes & Voting Matters
8-K · 2025-12-10
Periodic Financial Reports
10-Q · 2025-11-14
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.